Embattled Valeant (VRX) Reportedly Spurned a Takeover Offer from Takeda (TKPYY)-TPG
Genentech (RHHBY)’s Gazyva Meets Primary Endpoint Early in Late-Stage Study
Gilead (GILD), Biogen (BIIB), Jazz Pharma (JAZZ) Subpoenaed as Feds Investigate Drugmaker-Charity Connections
Bad News for AstraZeneca PLC (AZN) is Good News for Relypsa (RLYP)
Titan Pharma (TTNP) Receives FDA Approval for the First Ever Implantable Device for Opioid Dependency
Thermo Fisher Scientific (TMO) Expands into Pharma Market, Antes Up $4.2 Billion for FEI Company
Minerva Neurosciences (NERV)'s Stock More than Tripled on Positive Phase II Schizophrenia Drug Data
AstraZeneca PLC (AZN)'s Fulvestrant Meets Goals in Phase III Study
Aviragen Delays Further Enrollment in Phase IIa Trial of BTA585
Bay Area's Intuitive Surgical (ISRG) Accused of Hiding More than 700 Injury Claims Involving Its Da Vinci Surgical Robot, Says Insurer
ATCC Wins Infectious Diseases Contract Worth $101 Million From The NIAID
FORUM Pharma CEO Quits Amid Layoffs and a Possible Company Shutdown
3 Biotech Stocks Flying High Under-the-Radar
Only One Week After Voiding Two Years of Tests, Theranos Now Faces Consumer Class Action Lawsuit
Ionis Pharma (IONS) Plummets After GlaxoSmithKline (GSK) Opts Not to Initiate Phase III Study for Amyloid Cardiomyopathy Drug
Walgreens' Execs Ignored Doubts in Theranos' Technology in Fear of Deal Crumbling
Making Sense of Alnylam (ALNY)’s Recent Stock Surge
Novartis AG (NVS) Trial Stopped Early on Positive Data, Gets Ready to Take on Pfizer (PFE)'s Ibrance
See All News >
//-->